Daybreak Health

daybreakhealth.com →

-60%

est. 2Y upside i

HealthcareSeries B

The first digital mental health system for youth

Rank

#3386

Sector

Digital Health

Est. Liquidity

~3Y

Data Quality

Data: Medium

Downside risk dominates given stale valuation, negative revenue momentum, and high incumbent threat.

Last updated: July 3, 2026

Bull (10%)+5%

Revenue holds at $15M, exit multiple expands to 5x on IPO or category leadership, driving exit valuation to $75M. After preference and dilution, common sees 5% upside.

Base (35%)-33%

Revenue flat at $15M, exit multiple compresses to 4x, exit $60M. After preference and dilution, common returns -32.5%.

Bear (55%)-89%

Revenue declines further, exit multiple falls to 2.5x, exit $37.5M. Preference stack absorbs most value; after dilution, common loses 88.75%.

Est. time to liquidity~3.0 years

Preference Stack Risk

severe

Funding Intensity

38%

Total funding of $25M represents 38.5% of entry valuation, giving preferred a large claim.

Dilution Risk

high

With high burn and potential for down round, 20% dilution is assumed.

Secondary Liquidity

none

No secondary market or tender offer reported.

View all 37 open roles at Daybreak Health →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Daybreak Health's data — designed to show you've done your homework.

  • 1

    “How does the company plan to reverse revenue decline and compete against well-funded incumbents like Hazel Health and Brightline?”

  • 2

    “What is the current burn rate and timeline to breakeven?”

  • 3

    “What is the path to liquidity (M&A or IPO) given the current market conditions?”

Community

Valuation Sentiment

Our model estimates -60% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.